CARLSBAD, Calif., Nov. 7, 2024
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today
announced that management will participate in fireside chats at the
following investor conferences:
- Guggenheim's Inaugural Healthcare Conference on Wednesday, November 13, 2024
- UBS Global Healthcare Conference on Wednesday, November 13, 2024
- Stifel 2024 Healthcare Conference on Monday, November 18, 2024
- Jefferies London Healthcare Conference on Wednesday, November 20, 2024
- Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024
- Piper Sandler 36th
Annual Healthcare Conference on Wednesday,
December 4, 2024
A live webcast of these presentations can be accessed on the
Investors & Media section of the Ionis website at
https://ir.ionis.com/events-and-presentations/upcoming-events.
Replays will be available on the Ionis website within 48 hours and
will be archived for a limited time.
About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better
futures to people with serious diseases. Ionis currently has five
marketed medicines and a leading pipeline in neurology, cardiology,
and other areas of high patient need. As the pioneer in
RNA-targeted medicines, Ionis continues to drive innovation in RNA
therapies in addition to advancing new approaches in gene editing.
A deep understanding of disease biology and industry-leading
technology propels our work, coupled with a passion and urgency to
deliver life-changing advances for patients.
To learn more about Ionis, visit Ionis.com and follow us on X
(Twitter) and LinkedIn.
Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – ir@ionis.com
– 760-603-2331
Ionis Pharmaceuticals Media Contact:
Hayley Soffer –
media@ionis.com – 760-603-4679
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302297951.html
SOURCE Ionis Pharmaceuticals, Inc.